Raphaël Ortiz Joins Telix as Chief Operating Officer, EMEA
January 25, 2022 01:29 ET
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia and LIÈGE Belgium, Jan. 25, 2022 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that Raphaël Ortiz has joined the Company...
Japanese Prostate Cancer Imaging Study Completes Enrolment
September 08, 2021 18:57 ET
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia and KYOTO, Japan, Sept. 08, 2021 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that the last patient has been imaged in a...
Michael Didocha Joins Telix as Chief Financial Officer, Americas
August 31, 2021 07:12 ET
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia and INDIANAPOLIS, Aug. 31, 2021 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, ‘Telix’, the ‘Company’) is pleased to announce that Michael Didocha has joined the...
Mr. Ryoichi Tanaka Joins Telix Japan as Chief Operating Officer
August 05, 2021 18:14 ET
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia and KYOTO Japan, Aug. 05, 2021 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, ‘Telix’, the ‘Company’) is pleased to announce that Mr. Ryoichi Tanaka has joined the...
Ms. Helen Hovenga Joins Telix as Chief People Officer
August 03, 2021 17:48 ET
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia, Aug. 03, 2021 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, ‘Telix’, the ‘Company’) is pleased to announce that Ms. Helen Hovenga has joined the Telix executive...
Kyahn Williamson Joins Telix to Lead Corporate Communications and Investor Relations
July 11, 2021 18:40 ET
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia, July 11, 2021 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, ‘Telix’, the ‘Company’) is pleased to announce that Ms. Kyahn Williamson has joined the Telix...
First Patient Dosed in Japanese Prostate Cancer Imaging Study
May 24, 2021 21:04 ET
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia and KYOTO, Japan, May 25, 2021 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that the first patient has been dosed in a...
Telix and Monrol Expand Alliance to Include Lutetium Supply
May 10, 2021 18:57 ET
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia and ISTANBUL, Turkey, May 10, 2021 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that it has entered a global clinical supply...
Telix Pharmaceuticals Appoints Mr. Richard Valeix as EMEA President
May 02, 2021 19:15 ET
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia and HERSTAL, Belgium, May 02, 2021 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that Mr. Richard Valeix has joined the Telix...
Telix Pharmaceuticals Limited Acquires TheraPharm GmbH, Broadening Reach to Hematologic Cancers and Transplant Medicine
November 29, 2020 21:07 ET
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia and BAAR, Switzerland, Nov. 29, 2020 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, ‘Telix’, the ‘Company’) announces it has entered into an agreement with Scintec...